Back to search

Article

Liver-X receptor β-selective agonist CE9A215 regulates Alzheimer’s disease- associated pathology in a 3xTg-AD mouse model

2024-11-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> In Alzheimer's disease (AD), tau pathology is more closely associated with disease progression. Therefore, the development of agents that alleviate tau pathology is essential. Liver-X receptor (LXR), a nuclear receptor with α and β subunits, has garnered interest for the prevention and treatment of neurodegenerative diseases, especially AD. Inotodiol (CE9A215) is...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd5b9a63-4b95-5ef6-9afe-638e86b8fb61
DOI
10.21203/rs.3.rs-5357448/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Liver-X receptor β-selective agonist CE9A215 regulates Alzheimer’s disease- associated pathology in a 3xTg-AD mouse modelDOI 10.21203/rs.3.rs-5357448/v1
Select a neighboring publication to make it the new centre.